{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:51:15Z","timestamp":1793753475770,"version":"4.6.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007471","name":"Northern Borders University","doi-asserted-by":"publisher","award":["NBU-CRP-2025-2042"],"award-info":[{"award-number":["NBU-CRP-2025-2042"]}],"id":[{"id":"10.13039\/501100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32335-w","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:49:13Z","timestamp":1775821753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Activity of linalool based silver nanoconjugates against brain tumor through in silico, in vitro and in vivo evaluations"],"prefix":"10.1038","volume":"16","author":[{"given":"Hina","family":"Manzoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-5207","authenticated-orcid":false,"given":"Muhammad Umer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariha","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abida","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir Ali","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah R.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"32335_CR1","doi-asserted-by":"crossref","unstructured":"Pichaivel, M. et al. An Overview of Brain Tumor (IntechOpen, 2022).","DOI":"10.5772\/intechopen.100806"},{"issue":"11","key":"32335_CR2","doi-asserted-by":"publisher","first-page":"10565","DOI":"10.1021\/acsomega.3c00441","volume":"8","author":"S Kumari","year":"2023","unstructured":"Kumari, S. & Kumar, P. Design and computational analysis of an mmp9 inhibitor in hypoxia-induced glioblastoma multiforme. ACS Omega. 8 (11), 10565\u201310590 (2023).","journal-title":"ACS Omega"},{"issue":"12","key":"32335_CR3","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1073\/pnas.97.12.6242","volume":"97","author":"EC Holland","year":"2000","unstructured":"Holland, E. C. Glioblastoma multiforme: the terminator. Proc. Natl. Acad. Sci. 97 (12), 6242\u20136244 (2000).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"23","key":"32335_CR4","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp, R. et al. Effect of tumor-treating fields plus maintenance Temozolomide vs maintenance Temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. Jama 318 (23), 2306\u20132316 (2017).","journal-title":"Jama"},{"key":"32335_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","volume":"152","author":"C Alifieris","year":"2015","unstructured":"Alifieris, C. & Trafalis, D. T. Glioblastoma multiforme: pathogenesis and treatment. Pharmacol. Ther. 152, 63\u201382 (2015).","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"32335_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/07357907.2013.861474","volume":"32","author":"LJ Yang","year":"2014","unstructured":"Yang, L. J., Zhou, C. F. & Lin, Z. X. Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review. Cancer Invest. 32 (2), 31\u201336 (2014).","journal-title":"Cancer Invest."},{"key":"32335_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jconrel.2020.09.002","volume":"328","author":"GD Cha","year":"2020","unstructured":"Cha, G. D. et al. Advances in drug delivery technology for the treatment of glioblastoma multiforme. J. Controlled Release. 328, 350\u2013367 (2020).","journal-title":"J. Controlled Release"},{"issue":"7","key":"32335_CR8","doi-asserted-by":"publisher","first-page":"103698","DOI":"10.1016\/j.sjbs.2023.103698","volume":"30","author":"AT Rajendran","year":"2023","unstructured":"Rajendran, A. T. et al. Selection of potential natural compounds for poly-ADP-ribose polymerase (PARP) Inhibition in glioblastoma therapy by in Silico screening methods. Saudi J. Biol. Sci. 30 (7), 103698 (2023).","journal-title":"Saudi J. Biol. Sci."},{"key":"32335_CR9","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Remodelling and treatment of the blood-brain barrier in glioma. Cancer Manage. Res., : pp. 4217\u20134232. (2021).","DOI":"10.2147\/CMAR.S288720"},{"issue":"1","key":"32335_CR10","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","volume":"10","author":"A Galstyan","year":"2019","unstructured":"Galstyan, A. et al. Blood\u2013brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. Nat. Commun. 10 (1), 3850 (2019).","journal-title":"Nat. Commun."},{"issue":"1","key":"32335_CR11","first-page":"1534083","volume":"2022","author":"D A\u011fag\u00fcnd\u00fcz","year":"2022","unstructured":"A\u011fag\u00fcnd\u00fcz, D. et al. Cruciferous vegetables and their bioactive metabolites: from prevention to novel therapies of colorectal cancer. Evidence-based Complement. Altern. Med. 2022 (1), 1534083 (2022).","journal-title":"Evidence-based Complement. Altern. Med."},{"key":"32335_CR12","doi-asserted-by":"crossref","unstructured":"Sharma, M. et al. Essential Oils as Anticancer Agents: Potential Role in malignancies, Drug Delivery mechanisms, and Immune System Enhancement Vol. 146, p. 112514 (Biomedicine & Pharmacotherapy, 2022).","DOI":"10.1016\/j.biopha.2021.112514"},{"key":"32335_CR13","doi-asserted-by":"publisher","first-page":"105663","DOI":"10.1016\/j.fbio.2024.105663","volume":"63","author":"A Mahboob","year":"2025","unstructured":"Mahboob, A. et al. Food-derived phytochemicals from functional food (Allium sativum) as VEGF-R1 inhibitors: A novel approach for triple-negative breast cancer therapy. Food Bioscience. 63, 105663 (2025).","journal-title":"Food Bioscience"},{"issue":"3","key":"32335_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s12668-021-00880-z","volume":"11","author":"A Valizadeh","year":"2021","unstructured":"Valizadeh, A. et al. Anticarcinogenic effect of Chitosan nanoparticles containing syzygium aromaticum essential oil or Eugenol toward breast and skin cancer cell lines. BioNanoScience 11 (3), 678\u2013686 (2021).","journal-title":"BioNanoScience"},{"issue":"3","key":"32335_CR15","first-page":"625","volume":"20","author":"R Ravizza","year":"2008","unstructured":"Ravizza, R. et al. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells. Oncol. Rep. 20 (3), 625\u2013630 (2008).","journal-title":"Oncol. Rep."},{"issue":"4","key":"32335_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/01913123.2022.2091068","volume":"46","author":"H Elbe","year":"2022","unstructured":"Elbe, H. et al. Anticancer activity of linalool: comparative investigation of ultrastructural changes and apoptosis in breast cancer cells. Ultrastruct. Pathol. 46 (4), 348\u2013358 (2022).","journal-title":"Ultrastruct. Pathol."},{"issue":"1\u20132","key":"32335_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.tox.2009.11.013","volume":"268","author":"Y Gu","year":"2010","unstructured":"Gu, Y. et al. Linalool preferentially induces robust apoptosis of a variety of leukemia cells via upregulating p53 and cyclin-dependent kinase inhibitors. Toxicology 268 (1\u20132), 19\u201324 (2010).","journal-title":"Toxicology"},{"issue":"5-2023","key":"32335_CR18","first-page":"6","volume":"12","author":"L Xie","year":"2023","unstructured":"Xie, L. et al. \u03b1-Linalool from coriander root inhibits the proliferation and invasion of a human gastric cancer cell line. Clin. Cancer Invest. J. 12 (5-2023), 6\u201314 (2023).","journal-title":"Clin. Cancer Invest. J."},{"key":"32335_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1039\/c6pp00075d","volume":"15","author":"S Gunaseelan","year":"2016","unstructured":"Gunaseelan, S. et al. The preventive effect of Linalool on acute and chronic UVB-mediated skin carcinogenesis in Swiss albino mice. Photochem. Photobiol. Sci. 15, 851\u2013860 (2016).","journal-title":"Photochem. Photobiol. Sci."},{"issue":"11","key":"32335_CR20","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.3390\/molecules27113639","volume":"27","author":"KA Mansour","year":"2022","unstructured":"Mansour, K. A. et al. Nanoemulsions of Jasminum humile L. and Jasminum grandiflorum L. essential oils: an approach to enhance their cytotoxic and antiviral effects. Molecules 27 (11), 3639 (2022).","journal-title":"Molecules"},{"issue":"5","key":"32335_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/01635581.2014.904906","volume":"66","author":"S Jana","year":"2014","unstructured":"Jana, S. et al. Antitumorigenic potential of Linalool is accompanied by modulation of oxidative stress: an in vivo study in sarcoma-180 solid tumor model. Nutr. Cancer. 66 (5), 835\u2013848 (2014).","journal-title":"Nutr. Cancer"},{"issue":"5","key":"32335_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/10601325.2023.2195879","volume":"60","author":"Y An","year":"2023","unstructured":"An, Y. et al. Preparation and application of a novel pH-responsive Linalool carboxymethyl Chitosan hydrogel. J. Macromolecular Sci. Part. A. 60 (5), 336\u2013345 (2023).","journal-title":"J. Macromolecular Sci. Part. A"},{"issue":"2","key":"32335_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/hep4.1462","volume":"4","author":"K Ishiguro","year":"2020","unstructured":"Ishiguro, K. et al. Targeting liver cancer stem cells using engineered biological nanoparticles for the treatment of hepatocellular cancer. Hepatol. Commun. 4 (2), 298\u2013313 (2020).","journal-title":"Hepatol. Commun."},{"key":"32335_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.nano.2019.02.021","volume":"18","author":"HK Sanoff","year":"2019","unstructured":"Sanoff, H. K. et al. Phase I\/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer. Nanomed. Nanotechnol. Biol. Med. 18, 189\u2013195 (2019).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"14","key":"32335_CR25","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3390\/cells11142172","volume":"11","author":"MT Hsing","year":"2022","unstructured":"Hsing, M. T. et al. Improved delivery performance of n-butylidenephthalide-polyethylene glycol-gold nanoparticles efficient for enhanced anti-cancer activity in brain tumor. Cells 11 (14), 2172 (2022).","journal-title":"Cells"},{"key":"32335_CR26","doi-asserted-by":"crossref","unstructured":"Bin-Jumah, M. et al. Effects of green silver nanoparticles on apoptosis and oxidative stress in normal and cancerous human hepatic cells in vitro. Int. J. Nanomed., : pp. 1537\u20131548. (2020).","DOI":"10.2147\/IJN.S239861"},{"issue":"24","key":"32335_CR27","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.3390\/cancers14246120","volume":"14","author":"R Afjei","year":"2022","unstructured":"Afjei, R. et al. A new Nrf2 inhibitor enhances chemotherapeutic effects in glioblastoma cells carrying p53 mutations. Cancers 14 (24), 6120 (2022).","journal-title":"Cancers"},{"issue":"10","key":"32335_CR28","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1093\/neuonc\/noac105","volume":"24","author":"J Ding","year":"2022","unstructured":"Ding, J. et al. EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma. Neuro-oncology 24 (10), 1712\u20131725 (2022).","journal-title":"Neuro-oncology"},{"key":"32335_CR29","doi-asserted-by":"crossref","unstructured":"Villano, J. L. et al. Association of CDK4 Amplification with Duration of Response To Bevacizumab in Glioblastoma (American Society of Clinical Oncology, 2023).","DOI":"10.1200\/JCO.2023.41.16_suppl.2026"},{"issue":"1","key":"32335_CR30","doi-asserted-by":"publisher","first-page":"21486","DOI":"10.1038\/s41598-024-72475-z","volume":"14","author":"A Tharamelveliyil Rajendran","year":"2024","unstructured":"Tharamelveliyil Rajendran, A. et al. Uncovering naringin\u2019s anticancer mechanisms in glioblastoma via molecular Docking and network Pharmacology approaches. Sci. Rep. 14 (1), 21486 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"32335_CR31","doi-asserted-by":"publisher","first-page":"e14232","DOI":"10.2196\/14232","volume":"1","author":"SS Butt","year":"2020","unstructured":"Butt, S. S. et al. Molecular Docking using chimera and Autodock Vina software for nonbioinformaticians. JMIR Bioinf. Biotechnol. 1 (1), e14232 (2020).","journal-title":"JMIR Bioinf. Biotechnol."},{"key":"32335_CR32","doi-asserted-by":"crossref","unstructured":"Fernandez, M. & Goud, D. K. In-Silico Studies of RBP7, CALML3, C35, LGALSL, S100A3 Proteins Involved in Breast Cancer. Convergence of Technology & Biology Transforming Life Sciences, : pp. 127\u2013142. (2025).","DOI":"10.34293\/ctbtls.2025.ch013"},{"issue":"22","key":"32335_CR33","doi-asserted-by":"publisher","first-page":"16306","DOI":"10.3390\/ijms242216306","volume":"24","author":"Y Feng","year":"2023","unstructured":"Feng, Y. et al. A network Pharmacology prediction and molecular docking-based strategy to explore the potential Pharmacological mechanism of astragalus Membranaceus for glioma. Int. J. Mol. Sci. 24 (22), 16306 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"32335_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13568-023-01640-w","volume":"13","author":"A Sakhawat","year":"2023","unstructured":"Sakhawat, A. et al. Natural compound targeting BDNF V66M variant: insights from in Silico Docking and molecular analysis. Amb Express. 13 (1), 134 (2023).","journal-title":"Amb Express"},{"issue":"8","key":"32335_CR35","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3390\/medicina59081412","volume":"59","author":"AM Vyshnavi","year":"2023","unstructured":"Vyshnavi, A. M. In Silico analysis of the effect of hydrastis Canadensis on controlling breast cancer. Medicina 59 (8), 1412 (2023).","journal-title":"Medicina"},{"issue":"12","key":"32335_CR36","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1080\/07391102.2022.2087736","volume":"41","author":"V Chahal","year":"2023","unstructured":"Chahal, V. & Kakkar, R. A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor linked human carbonic anhydrase IX. J. Biomol. Struct. Dynamics. 41 (12), 5465\u20135480 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"issue":"3","key":"32335_CR37","doi-asserted-by":"publisher","first-page":"e0318539","DOI":"10.1371\/journal.pone.0318539","volume":"20","author":"S Jabeen","year":"2025","unstructured":"Jabeen, S. et al. Identifying novel inhibitors against drug-resistant mutant CYP-51 Candida albicans: A computational study to combat fungal infections. PLoS One. 20 (3), e0318539 (2025).","journal-title":"PLoS One"},{"issue":"10","key":"32335_CR38","doi-asserted-by":"publisher","first-page":"e0333617","DOI":"10.1371\/journal.pone.0333617","volume":"20","author":"H Manzoor","year":"2025","unstructured":"Manzoor, H. et al. Novel Linalool-Silver nanoparticles: Synthesis, characterization, and dual approach evaluation via computational Docking and antibacterial assays. PLoS One. 20 (10), e0333617 (2025).","journal-title":"PLoS One"},{"issue":"5","key":"32335_CR39","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3724\/abbs.2023065","volume":"55","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. LncRNA RMST suppresses the progression of colorectal cancer by competitively binding to miR-27a-3p\/RXR\u03b1 axis and inactivating Wnt signaling pathway: RMST suppresses the progression of colorectal cancer. Acta Biochim. Biophys. Sin. 55 (5), 726 (2023).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"32335_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1023\/A:1012222522359","volume":"53","author":"PE Kish","year":"2001","unstructured":"Kish, P. E. et al. Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J. Neurooncol. 53, 243\u2013257 (2001).","journal-title":"J. Neurooncol."},{"issue":"1","key":"32335_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12906-023-04266-4","volume":"23","author":"M Osanloo","year":"2023","unstructured":"Osanloo, M. et al. Comparison effects of ferula gummosa essential oil and Beta-pinene alginate nanoparticles on human melanoma and breast cancer cells proliferation and apoptotic index in short term Normobaric hyperoxic model. BMC Complement. Med. Ther. 23 (1), 428 (2023).","journal-title":"BMC Complement. Med. Ther."},{"key":"32335_CR42","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s11033-019-05219-2","volume":"47","author":"S Mirabdaly","year":"2020","unstructured":"Mirabdaly, S. et al. Effects of Temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties. Mol. Biol. Rep. 47, 1187\u20131197 (2020).","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"32335_CR43","doi-asserted-by":"publisher","first-page":"e0325281","DOI":"10.1371\/journal.pone.0325281","volume":"20","author":"H Manzoor","year":"2025","unstructured":"Manzoor, H. et al. Linalool-based silver nanoconjugates as potential therapeutics for glioblastoma: in Silico and in vitro insights. PloS One. 20 (6), e0325281 (2025).","journal-title":"PloS One"},{"issue":"1","key":"32335_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41984-024-00294-5","volume":"39","author":"M Sabouri","year":"2024","unstructured":"Sabouri, M. et al. Survival rate of patient with glioblastoma: a population-based study. Egypt. J. Neurosurg. 39 (1), 42 (2024).","journal-title":"Egypt. J. Neurosurg."},{"key":"32335_CR45","doi-asserted-by":"crossref","unstructured":"McAleenan, A. et al. Prognostic Value of Test (s) for O6-methylguanine\u2013DNA Methyltransferase (MGMT) Promoter Methylation for Predicting Overall Survival in People with Glioblastoma Treated with Temozolomide. Cochrane Database of Systematic Reviews, 2021(3).","DOI":"10.1002\/14651858.CD013316.pub2"},{"issue":"6","key":"32335_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/life14060673","volume":"14","author":"D Smerdi","year":"2024","unstructured":"Smerdi, D. et al. Overcoming resistance to Temozolomide in glioblastoma: a scoping review of preclinical and clinical data. Life 14 (6), 673 (2024).","journal-title":"Life"},{"key":"32335_CR47","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1007\/s11033-021-06578-5","volume":"48","author":"BI Silva","year":"2021","unstructured":"Silva, B. I. et al. Anticancer activity of monoterpenes: A systematic review. Mol. Biol. Rep. 48, 5775\u20135785 (2021).","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"32335_CR48","doi-asserted-by":"publisher","first-page":"14127","DOI":"10.3390\/ijms131114127","volume":"13","author":"Y Lu","year":"2012","unstructured":"Lu, Y. et al. Bioavailability and brain-targeting of Geniposide in gardenia-borneol co-compound by different administration routes in mice. Int. J. Mol. Sci. 13 (11), 14127\u201314135 (2012).","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"32335_CR49","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.2217\/nnm-2018-0417","volume":"14","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Improved brain delivery of pueraria flavones via intranasal administration of borneol-modified solid lipid nanoparticles. Nanomedicine 14 (16), 2105\u20132119 (2019).","journal-title":"Nanomedicine"},{"key":"32335_CR50","first-page":"1","volume":"12","author":"N Radhakrishnan","year":"2021","unstructured":"Radhakrishnan, N. et al. Caffeic acid phenethyl ester (CAPE) confers wild type p53 function in p53 Y220C mutant: bioinformatics and experimental evidence. Discover Oncol. 12, 1\u201313 (2021).","journal-title":"Discover Oncol."},{"key":"32335_CR51","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.crstbi.2022.09.002","volume":"4","author":"S Shefrin","year":"2022","unstructured":"Shefrin, S. et al. Comparative computational and experimental analyses of some natural small molecules to restore transcriptional activation function of P53 in cancer cells harbouring wild type and P53Ser46 mutant. Curr. Res. Struct. Biology. 4, 320\u2013331 (2022).","journal-title":"Curr. Res. Struct. Biology"},{"issue":"12","key":"32335_CR52","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.1093\/nar\/gkt305","volume":"41","author":"X Liu","year":"2013","unstructured":"Liu, X. et al. Small molecule induced reactivation of mutant p53 in cancer cells. Nucleic Acids Res. 41 (12), 6034\u20136044 (2013).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"32335_CR53","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.5808\/gi.21062","volume":"19","author":"S Rath","year":"2021","unstructured":"Rath, S., Jagadeb, M. & Bhuyan, R. Molecular Docking of bioactive compounds derived from Moringa Oleifera with p53 protein in the apoptosis pathway of oral squamous cell carcinoma. Genomics Inf. 19 (4), e46 (2021).","journal-title":"Genomics Inf."},{"issue":"9","key":"32335_CR54","doi-asserted-by":"publisher","first-page":"180112","DOI":"10.1098\/rsob.180112","volume":"8","author":"DJ Wood","year":"2018","unstructured":"Wood, D. J. & Endicott, J. A. Structural insights into the functional diversity of the CDK\u2013cyclin family. Open. Biology. 8 (9), 180112 (2018).","journal-title":"Open. Biology"},{"issue":"5","key":"32335_CR55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/md20050319","volume":"20","author":"L Luo","year":"2022","unstructured":"Luo, L., Wang, Q. & Liao, Y. The inhibitors of CDK4\/6 from a library of marine compound database: A pharmacophore, ADMET, molecular Docking and molecular dynamics study. Mar. Drugs. 20 (5), 319 (2022).","journal-title":"Mar. Drugs"},{"issue":"1","key":"32335_CR56","first-page":"2407462","volume":"2022","author":"C Wu","year":"2022","unstructured":"Wu, C. et al. Exploring the mechanism of Curcumin on retinoblastoma based on network Pharmacology and molecular Docking. Evidence-Based Complement. Altern. Med. 2022 (1), 2407462 (2022).","journal-title":"Evidence-Based Complement. Altern. Med."},{"key":"32335_CR57","doi-asserted-by":"crossref","unstructured":"Kusumorini, A. et al. In-Silico Analysis of Eugenol and Beta-Caryophyllene Compounds in Clove (Syzygium aromaticum L.) on NF-kB Protein As Anti-inflammatory Agent In Atherosclerosis. Elkawnie: Journal of Islamic Science and Technology, 10(1): pp. 88\u2013102. (2024).","DOI":"10.22373\/ekw.v10i1.17387"},{"issue":"2","key":"32335_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.47262\/SL\/9.2.132021007","volume":"9","author":"DS Metibemu","year":"2021","unstructured":"Metibemu, D. S. 3D-QSAR and molecular Docking approaches for the identification of novel phyto-inhibitors of the cyclin-dependent kinase 4. Sci. Lett. 9 (2), 42\u201348 (2021).","journal-title":"Sci. Lett."},{"issue":"10","key":"32335_CR59","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1002\/ptr.7547","volume":"36","author":"PH Patil","year":"2022","unstructured":"Patil, P. H. et al. Molecular dynamics simulation and in vitro evaluation of herb\u2013drug interactions involving dietary polyphenols and CDK inhibitors in breast cancer chemotherapy. Phytother. Res. 36 (10), 3988\u20134001 (2022).","journal-title":"Phytother. Res."},{"issue":"5","key":"32335_CR60","doi-asserted-by":"publisher","first-page":"bbab098","DOI":"10.1093\/bib\/bbab098","volume":"22","author":"F Ahammad","year":"2021","unstructured":"Ahammad, F. et al. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of Neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein. Brief. Bioinform. 22 (5), bbab098 (2021).","journal-title":"Brief. Bioinform."},{"key":"32335_CR61","doi-asserted-by":"crossref","unstructured":"Liang, S. et al. Molecular mechanism concerning conformational changes of CDK2 mediated by binding of inhibitors using molecular dynamics simulations and principal component analysis. SAR and QSAR in Environmental Research, 32(7): pp. 573\u2013594. (2021).","DOI":"10.1080\/1062936X.2021.1934896"},{"issue":"4","key":"32335_CR62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00894-023-05496-6","volume":"29","author":"S Nagare","year":"2023","unstructured":"Nagare, S., Lokhande, K. B. & Swamy, K. V. Docking and simulation studies on Cyclin D\/CDK4 complex for targeting cell cycle arrest in cancer using Flavanone and its congener. J. Mol. Model. 29 (4), 90 (2023).","journal-title":"J. Mol. Model."},{"key":"32335_CR63","doi-asserted-by":"crossref","unstructured":"Rani, N. & Kumar, P. Exploring natural compounds as potential CDK4 inhibitors for therapeutic intervention in neurodegenerative diseases through computational analysis. Mol. Biotechnol., : pp. 1\u201320. (2024).","DOI":"10.1007\/s12033-024-01258-8"},{"issue":"4","key":"32335_CR64","doi-asserted-by":"publisher","first-page":"e22223","DOI":"10.1002\/ddr.22223","volume":"85","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. & Chen, D. Validating Linalool as a potential drug for breast cancer treatment based on machine learning and molecular Docking. Drug Dev. Res. 85 (4), e22223 (2024).","journal-title":"Drug Dev. Res."},{"issue":"10","key":"32335_CR65","doi-asserted-by":"publisher","first-page":"102231","DOI":"10.1016\/j.clinre.2023.102231","volume":"47","author":"P Tamilmani","year":"2023","unstructured":"Tamilmani, P. et al. Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1\/Akt\/PPRA-\u03b1\/AMPK and Nrf-2\/HO-1 signaling pathways. Clin. Res. Hepatol. Gastroenterol. 47 (10), 102231 (2023).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"6","key":"32335_CR66","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s40495-024-00377-9","volume":"10","author":"R Huda","year":"2024","unstructured":"Huda, R. et al. Role of terpenoids in breast cancer prevention and therapy. Curr. Pharmacol. Rep. 10 (6), 436\u2013446 (2024).","journal-title":"Curr. Pharmacol. Rep."},{"issue":"24","key":"32335_CR67","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.3390\/molecules29246044","volume":"29","author":"M Russo","year":"2024","unstructured":"Russo, M. et al. Lavender essential oil and its terpenic components negatively affect tumor properties in a cell model of glioblastoma. Molecules 29 (24), 6044 (2024).","journal-title":"Molecules"},{"issue":"4","key":"32335_CR68","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s12649-023-02314-1","volume":"15","author":"H Sahib Abed","year":"2024","unstructured":"Sahib Abed, H. et al. Inhibition the growth of human ovarian cancer cells (A2780) via cell proliferation and angiogenesis by viola odorata essential oil nanoemulsion. Waste Biomass Valoriz. 15 (4), 2417\u20132426 (2024).","journal-title":"Waste Biomass Valoriz."},{"issue":"6","key":"32335_CR69","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1080\/01480545.2021.1957563","volume":"45","author":"A Salimi","year":"2022","unstructured":"Salimi, A. et al. Linalool reverses benzene-induced cytotoxicity, oxidative stress and lysosomal\/mitochondrial damages in human lymphocytes. Drug Chem. Toxicol. 45 (6), 2454\u20132462 (2022).","journal-title":"Drug Chem. Toxicol."},{"key":"32335_CR70","doi-asserted-by":"crossref","unstructured":"Ding, H. et al. Linalool suppresses proliferation and promotes apoptosis in gastric cancer cells via activation of reactive oxygen Species-Mediated P53 pathway. Curr. Top. Nutraceutical Res., 18(4). (2020).","DOI":"10.37290\/ctnr2641-452X.18:325-330"},{"issue":"2","key":"32335_CR71","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11060-007-9400-9","volume":"85","author":"M Candolfi","year":"2007","unstructured":"Candolfi, M. et al. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J. Neurooncol. 85 (2), 133\u2013148 (2007).","journal-title":"J. Neurooncol."},{"issue":"5","key":"32335_CR72","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/jnen\/nlac021","volume":"81","author":"U Sahu","year":"2022","unstructured":"Sahu, U. et al. Rat and mouse brain tumor models for experimental neuro-oncology research. J. Neuropathology Experimental Neurol. 81 (5), 312\u2013329 (2022).","journal-title":"J. Neuropathology Experimental Neurol."},{"key":"32335_CR73","doi-asserted-by":"publisher","first-page":"103649","DOI":"10.1016\/j.jddst.2022.103649","volume":"76","author":"H Syama","year":"2022","unstructured":"Syama, H. et al. Bio fabrication of Galactomannan capped silver nanoparticles to apprehend Ehrlich Ascites carcinoma solid tumor in mice. J. Drug Deliv. Sci. Technol. 76, 103649 (2022).","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"32335_CR74","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12645-022-00143-w","volume":"13","author":"DG Lee","year":"2022","unstructured":"Lee, D. G. et al. Resveratrol-loaded gold nanoparticles enhance caspase-mediated apoptosis in PANC-1 pancreatic cells via mitochondrial intrinsic apoptotic pathway. Cancer Nanotechnol. 13 (1), 34 (2022).","journal-title":"Cancer Nanotechnol."},{"issue":"3","key":"32335_CR75","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/jemt.24724","volume":"88","author":"M Se\u00e7me","year":"2025","unstructured":"Se\u00e7me, M. & \u0130lhan, H. Synthesis and characterization of thymol carbon nanodot functionalized silver nanoparticles (ThCND-AgNPs) and evaluation of their Antiproliferative, Anti\u2010Invasive, and apoptotic effects on OVCAR\u20103 ovarian cancer cells. Microsc. Res. Tech. 88 (3), 668\u2013677 (2025).","journal-title":"Microsc. Res. Tech."},{"key":"32335_CR76","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.adcanc.2025.100139","volume":"14","author":"S Homaeii","year":"2025","unstructured":"Homaeii, S., Kavousi, M. & Asgari, E. A. Investigating the apoptotic and antimetastatic effect of daphnetin-containing nano niosomes on MCF-7 cells. Adv. Cancer Biology-Metastasis. 14, 100139 (2025).","journal-title":"Adv. Cancer Biology-Metastasis"},{"key":"32335_CR77","doi-asserted-by":"publisher","first-page":"110147","DOI":"10.1016\/j.intimp.2023.110147","volume":"119","author":"R Verma","year":"2023","unstructured":"Verma, R., Rani, V. & Kumar, M. -vivo anticancer efficacy of self-targeted methotrexate-loaded polymeric nanoparticles in solid tumor-bearing rat. Int. Immunopharmacol. 119, 110147 (2023).","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"32335_CR78","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.3390\/ma16083238","volume":"16","author":"A Vasil\u2019kov","year":"2023","unstructured":"Vasil\u2019kov, A. et al. Evolution of gold and iron oxide nanoparticles in conjugates with methotrexate: synthesis and anticancer effects. Materials 16 (8), 3238 (2023).","journal-title":"Materials"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32335-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:04:04Z","timestamp":1776089044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32335-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32335"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32335-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12216"}}